Navigation Links
JS Genetics Develops New Non-Invasive Test, XCAT-TS, to Help Doctors Diagnose Turner Syndrome
Date:3/3/2011

s.com.

About JS Genetics

JS Genetics Inc., a private company, develops and markets proprietary, high value DNA diagnostic tests for medical conditions in newborns, children, and adolescents.  In the past 4 years, JS Genetics has been awarded 4 Phase I and 3 Phase II Small Business Innovation Research (SBIR) grants from the National Institutes of Health.  The company's strategy is to develop tests using cheek swabs for sample collection on a PCR based testing platform to bring to market accurate, convenient and scalable DNA diagnostics.  

Other tests currently under development include:

  • Non-Karyotype cheek swab test for detection of Klinefelter Syndrome
  • Non-Karyotype test for detection of Down Syndrome
  • Cheek swab test for Dyslexia predisposition
  • Non-Southern Blot, cheek swab test for detection of Fragile X Syndrome

All test are developed and performed in our CLIA certified (ID# 07D1091103) and CAP accredited (CAP# 72115351) laboratory in New Haven CT.


'/>"/>
SOURCE JS Genetics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Genetics Determine Optimal Drug Dose of Common Anticoagulant
4. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
5. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
6. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
7. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
8. deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
9. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
10. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
11. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... New high priced hepatitis C drugs will increase federal ... to $5.8 billion next year, according to a new ... the Pharmaceutical Care Management Association (PCMA). Milliman projects that ... as 8.6 percent in 2015 as a result of ... The study finds that the majority of new ...
(Date:7/29/2014)... Numotion,s Board of Directors has announced that as ... the company,s new Chief Executive Officer. Swinford ... where he worked primarily for GE Healthcare Services, running businesses ... billion. His most recent position was as President and CEO ... thrilled to join Numotion," said Mike Swinford . "I ...
(Date:7/29/2014)... July 29, 2014  Roche (SIX: RO, ROG; OTCQX: ... Clinical Chemistry (AACC) 2014 Clinical Lab Expo today by ... unique ways Roche is partnering with customers to redefine ... tell us every day that they,re looking for a ... in their labs and offices," said Jack Phillips ...
Breaking Medicine Technology:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Numotion Names Mike Swinford CEO 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4
(Date:7/29/2014)... 30, 2014 Dignity Sciences Limited, a ... of a Phase I trial with DS107G, an oral ... study was a randomized, placebo-controlled, double-blind, single-ascending and multiple ... pharmacokinetics and effect of food on DS107G in healthy ... profile of DGLA following both single and multiple oral ...
(Date:7/29/2014)... have discovered a chemical alteration in a single human ... larger studies, could give doctors a simple blood test ... , The discovery, described online in The American ... gene involved in the function of the brain,s response ... what might otherwise be an unremarkable reaction to the ...
(Date:7/29/2014)... Denver, Colorado (PRWEB) July 29, 2014 Daily ... the author of this program claims that he cured his ... the author decided to share part of his experience. ... nasal polys permanently and naturally in just 4 days. Since ... share it with sufferers from all around the world. ...
(Date:7/29/2014)... Denver, Colorado (PRWEB) July 29, 2014 Daily ... program was created by a holistic nutritional and functional medicine ... way of overcoming this problem. , Karen suffered from leaky ... so much time to develop this unique treatment. , ... her method, with sufferers from all around the world. The ...
(Date:7/29/2014)... Washington, New York (PRWEB) July 29, 2014 ... to protecting the rights of victims injured by defective ... lawsuit has been filed by plaintiffs in Canada who ... risk of cardiovascular events with the low testosterone ... filed on July 22, 2014 in the Ontario Superior ...
Breaking Medicine News(10 mins):Health News:DS107G-01 – Successful Completion of Phase I Oral DGLA Clinical Trial 2Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3Health News:Nasal Polyps Treatment Miracle Review Reveals How to Cure Nasal Polyps Without Surgery 2Health News:Leaky Gut Cure Review Reveals Karen Brimeyer’s Natural Way to Heal Leaky Gut 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 3
... Fla., Dec. 13 The Quantum Group,Inc. (Amex: ... it,has completed its registered public offering, raising $13.2 ... it has initiated trading,on the American Stock Exchange ... the symbol "QGP.U." In addition, Quantum common shares,formerly ...
... for the Hospital,s ... State-of-the-Art Cardiothoracic Center, SANTA CLARA, Calif., Dec. ... a new network,infrastructure to support a trust-wide Picture Archiving ... Hospitals, part,of the NHS Foundation Trust in Essex, United ...
... plan services for members, ROCKVILLE, Md., Dec. ... of comprehensive dental plans and administration, has,announced a ... the,nation,s leading integrated health plan provider. GDS will ... and,call center support to Kaiser Permanente Northwest,s 180,000 ...
... NEW YORK, Dec. 13 Getting in shape shouldn,t ... a public health,advocate and veteran of the fitness industry. ... Year, Holland has developed a novel fitness,program to help ... Ease-In Longevity program allows people to "ease into," exercise,going ...
... to 100,000-fold, study finds , , THURSDAY, Dec. 13 (HealthDay News) ... team reports that tiny fibers commonly found in semen drastically ... , According to a study in the Dec. 14 issue ... then ferry it to target cells, increasing its ability to ...
... human spine evolved differently in males and females in ... carrying a baby, according to research spearheaded at The ... are documented for the first time in the Dec. ... adaptation first appeared at least two million years ago, ...
Cached Medicine News:Health News:The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP' 2Health News:The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP' 3Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 3Health News:Fitness Guru Offers Novel Exercise Program and Tips to Stick with Exercise in the New Year 2Health News:Fibers in Semen Help HIV Penetrate Cells 2Health News:Adapting to pregnancy played key role in human evolution, study shows 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: